SCHEMBL617215

SCHEMBL617215

Cc1nc2ncccc2cc1C(=O)NCc1ccc(N2CCN(C)CC2)c(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 3/20 0.46
PDGFRA P16234 2/20 0.46
FLT4 P35916 2/20 0.46
FLT3 P36888 2/20 0.46
KCNH2 Q12809 2/20 0.46
TRPV1 Q8NER1 2/20 0.44
AURKA O14965 1/20 0.43
PDPK1 O15530 1/20 0.43
RPS6KB1 P23443 1/20 0.43
AURKB Q96GD4 1/20 0.43
HRH4 Q9H3N8 1/20 0.43
TACR1 P25103 1/20 0.42
CCNA2 P20248 2/20 0.42
CDK2 P24941 2/20 0.42
CCNA1 P78396 2/20 0.42
EPHX2 P34913 2/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NR3C1 P04150 1/20 0.41
KDR P35968 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL619784 0.92 TRPV1 (0.53) TRPV1HTTSMN1; SMN2NR3C1KDM4E
SCHEMBL617313 0.92 ENPP2 (0.46) CSF1RPDGFRAFLT4FLT3KCNH2
SCHEMBL616887 0.91 CSF1R (0.47) CSF1RTRPV1AURKARPS6KB1AURKB
SCHEMBL619224 0.90 TRPV1 (0.43) CSF1RPDGFRAFLT4FLT3KCNH2
SCHEMBL248208 0.85 TRPV1 (0.47) CSF1RPDGFRAFLT4FLT3KCNH2
SCHEMBL10232885 0.84 SMN1; SMN2 (0.48) RPS6KB1HTTSMN1; SMN2NR3C1
SCHEMBL252248 0.83 CD38 (0.42) TRPV1HTTSMN1; SMN2NR3C1ALDH1A1
SCHEMBL620104 0.82 NR3C1 (0.54) TRPV1AURKARPS6KB1AURKBHTT
SCHEMBL619617 0.81 HTT (0.45) RPS6KB1HTTSMN1; SMN2NR3C1
SCHEMBL620473 0.81 PTGDR2 (0.47) RPS6KB1HTTSMN1; SMN2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401275-B1 NAPHTHYRIDINE DERIVATIVES HAVING BRONCHODILATING ACTIVITY RESPIRATORIUS AB (SE) 2013-07-24 EP claimed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US claimed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US claimed
EP-2401275-B1 NAPHTHYRIDINE DERIVATIVES HAVING BRONCHODILATING ACTIVITY RESPIRATORIUS AB (SE) 2013-07-24 EP disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US disclosed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US disclosed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS CHRM3, ADRB1, ADRB3 CSF1R 2020/4885PDGFRA 2452/4885FLT4 3608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.